Investment Q&A

• Intuitive Surgical Inc. (ISRG $586.24)
  • $586.24 P/E (TTM): 77.44X Cap: $207.81B
  • View ISRG Profile
  • View Questions on ISRG
• Eli Lilly and Company (LLY $1,063.56)
  • $1,063.56 P/E (TTM): 52.03X Cap: $1T
  • View LLY Profile
  • View Questions on LLY
• Veeva Systems Inc. Class A (VEEV $240.12)
  • $240.12 P/E (TTM): 46.81X Cap: $39.47B
  • View VEEV Profile
  • View Questions on VEEV

Q: Could you please comment on VEEV earnings? Is it still a buy? If I wanted to replace it with another stock, any suggestions? Thanks.

Upvote 1

Read Answer Asked by William on May 31, 2024

• Tandem Diabetes Care Inc. (TNDM $21.70)
  • $21.70 Cap: $1.47B
  • View TNDM Profile
  • View Questions on TNDM

Q: Hello 5i ,
I owned Tandem Diabetes for years and sold it in April 2022.
I see its share price has been on a steep incline of late. Can you shed some light on what might be causing this?
Thank you
Dave

Upvote 1

Read Answer Asked by Dave on May 31, 2024

• UnitedHealth Group Incorporated (DE) (UNH $343.98)
  • $343.98 P/E (TTM): 17.94X Cap: $311.58B
  • View UNH Profile
  • View Questions on UNH

Q: Your thoughts please on United Health and the recent information that caused a pull back in the price?

Upvote 2

Read Answer Asked by Dan on May 30, 2024

• Savaria Corporation (SIS $23.86)
  • $23.86 P/E (TTM): 27.74X Cap: $1.70B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Any news lately on SIS Savaria. Stock has been up consistently. What do you see the near future of Savaria ie any more acquisitions or growth

Upvote 4

Read Answer Asked by Barry on May 27, 2024

• AbbVie Inc. (ABBV $220.08)
  • $220.08 P/E (TTM): 168.0X Cap: $388.96B
  • View ABBV Profile
  • View Questions on ABBV
• Abbott Laboratories (ABT $125.92)
  • $125.92 P/E (TTM): 15.8X Cap: $218.95B
  • View ABT Profile
  • View Questions on ABT
• Eli Lilly and Company (LLY $1,063.56)
  • $1,063.56 P/E (TTM): 52.03X Cap: $1T
  • View LLY Profile
  • View Questions on LLY
• Novo Nordisk A/S (NVO $58.81)
  • $58.81 P/E (TTM): 16.66X Cap: $363.68B
  • View NVO Profile
  • View Questions on NVO
• iShares U.S. Medical Devices ETF (IHI $63.94)
  • $63.94 P/E (TTM): 30.27X Cap: $4.15B
  • View IHI Profile
  • View Questions on IHI

Q: I am underwhelmed with my health sector holdings - ABBV and IHI - both of which have been recently underperforming the market. I have held each for several years in a cash account and they are up 20% and 50%, respectively. I would appreciate your go forward recommendation on both, balancing future prospects, tax consequences and alternative (i.e. faster growing) investments in this sector. Hold or sell? And if sell, replace with what? Thank you.

Upvote 11

Read Answer Asked by Maureen on May 24, 2024

• Vitalhub Corp. (VHI $9.11)
  • $9.11 P/E (TTM): 178.63X Cap: $575M
  • View VHI Profile
  • View Questions on VHI
  • View Reports on VHI
• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: For a growth investment, I am looking at either WELL or VHI. Which one would you choose and why?

Thanks

Upvote 7

Read Answer Asked by Chuck on May 23, 2024

• Danaher Corporation (DHR $238.37)
  • $238.37 P/E (TTM): 49.05X Cap: $168.37B
  • View DHR Profile
  • View Questions on DHR
• Charles River Laboratories International Inc. (CRL $220.91)
  • $220.91 Cap: $10.66B
  • View CRL Profile
  • View Questions on CRL

Q: Which of these Life Sciences companies would you prefer and why? Thanks for your service!

Upvote 3

Read Answer Asked by Michael on May 23, 2024

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Hello 5i,

When I look at a chart of WELL, I see that its momentum is not horrible but not good either. When I read 5i's responses to members, I see that his opinion is rather favorable about this company. My question is: If 5i had never had a position in WELL, would he consider initiating one now or would he wait until the momentum has improved?

Thank you

Upvote 11

Read Answer Asked by Charles on May 22, 2024

• Novavax Inc. (NVAX $7.27)
  • $7.27 P/E (TTM): 3.85X Cap: $1.18B
  • View NVAX Profile
  • View Questions on NVAX

Q: a buddy of mine recently bought this stock at $4 and in the last week its been as high as $14 and now he thinks he's warren Buffett , is there a reason for the sudden jump in share price ? thanks and have a super long weekend.

Upvote 1

Read Answer Asked by jim on May 21, 2024

• Ocugen, Inc. (OCGN $1.50)
  • $1.50 Cap: $431M
  • View OCGN Profile
  • View Questions on OCGN

Q: do you folks have any info on ocgn ? thanks

Upvote 2

Read Answer Asked by jim on May 17, 2024

• Quipt Home Medical Corp. (QIPT $4.92)
  • $4.92 Cap: $216M
  • View QIPT Profile
  • View Questions on QIPT

Q: Thoughts on latest earnings and hold,add to,or sell and explanation please. Thanx.

Upvote 1

Read Answer Asked by Steve on May 16, 2024

• Cipher Pharmaceuticals Inc. (CPH $15.46)
  • $15.46 P/E (TTM): 16.64X Cap: $392M
  • View CPH Profile
  • View Questions on CPH
  • View Reports on CPH

Q: Would appreciate your analysis of CPH's Q1 results that were released last week.

Upvote 2

Read Answer Asked by karl on May 16, 2024

• Danaher Corporation (DHR $238.37)
  • $238.37 P/E (TTM): 49.05X Cap: $168.37B
  • View DHR Profile
  • View Questions on DHR
• Thermo Fisher Scientific Inc (TMO $618.86)
  • $618.86 P/E (TTM): 35.75X Cap: $232.51B
  • View TMO Profile
  • View Questions on TMO

Q: I have below weight holdings in DHR and TMO and am looking to sell my holdings in one of these and use the proceeds to increase my holdings in the other. Which of these 2 do you prefer.

Thanks

Peter

Upvote 3

Read Answer Asked by Peter on May 16, 2024

• Quest Diagnostics Incorporated (DGX $174.44)
  • $174.44 P/E (TTM): 20.47X Cap: $19.40B
  • View DGX Profile
  • View Questions on DGX

Q: What are you current thoughts on this company and its possible purchase of lifelabs?

Upvote 1

Read Answer Asked by Danny-boy on May 15, 2024

• NVIDIA Corporation (NVDA $184.86)
  • $184.86 P/E (TTM): 45.87X Cap: $4.49T
  • View NVDA Profile
  • View Questions on NVDA
• Recursion Pharmaceuticals Inc. (RXRX $4.66)
  • $4.66 Cap: $2.52B
  • View RXRX Profile
  • View Questions on RXRX

Q: What do you think of this company and its future? Is it a buy hold or sell.
Thank you

Upvote 5

Read Answer Asked by patricia on May 14, 2024

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Hello ,
It appears from various questions and answers, well's fundamentals are good. If the market does not seem to like it much, in your experience, is it best to move on. Unless there is a takeover, do you see a potential of Well surging. Last report as outlined was good and it did well but now retracing.. thanks for your assistance.

Upvote 16

Read Answer Asked by umedali on May 14, 2024

• Knight Therapeutics Inc. (GUD $5.98)
  • $5.98 Cap: $596M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Thoughts please on their latest quarter, I think I can guess :-)
Do you see any signs pointing to a turn around?
Thanks!

Upvote 7

Read Answer Asked by Robert on May 13, 2024

• CVS Health Corporation (CVS $80.30)
  • $80.30 P/E (TTM): 211.32X Cap: $101.93B
  • View CVS Profile
  • View Questions on CVS

Q: Thinking of taking a position. Seems oversold for a quality company. What are your thoughts for short and long term buys?

Upvote 2

Read Answer Asked by Bernie on May 13, 2024

• CloudMD Software & Services Inc. (DOC $0.04)
  • View DOC Profile
  • View Questions on DOC

Q: thoughts and projecting 5 years

Upvote 1

Read Answer Asked by cliff on May 13, 2024

• WELL Health Technologies Corp. (WELL $4.23)
  • $4.23 Cap: $1.07B
  • View WELL Profile
  • View Questions on WELL
  • View Reports on WELL

Q: Results were good. Market is not supporting Well. What's missing. I just don't get this one.

Upvote 10

Read Answer Asked by John on May 10, 2024